Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes

Serruys, Patrick W; Onuma, Yoshinobu; Dudek, Dariusz; Smits, Pieter C; Koolen, Jacques; Chevalier, Bernard; de Bruyne, Bernard; Thuesen, Leif; McClean, Dougal; van Geuns, Robert-Jan; Windecker, Stephan; Whitbourn, Robert; Meredith, Ian; Dorange, Cecile; Veldhof, Susan; Hebert, Karine Miquel; Sudhir, Krishnankutty; Garcia-Garcia, Hector M; Ormiston, John A (2011). Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging outcomes. Journal of the American College of Cardiology, 58(15), pp. 1578-88. New York, N.Y.: Elsevier 10.1016/j.jacc.2011.05.050

Full text not available from this repository. (Request a copy)

The aim of this study was to demonstrate that the prevention of early scaffold area shrinkage of the ABSORB BVS (Rev.1.1, Abbott Vascular, Santa Clara, California) was sustained and not simply delayed by a few months.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

UniBE Contributor:

Windecker, Stephan

ISSN:

0735-1097

Publisher:

Elsevier

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 14:21

Last Modified:

17 Mar 2015 19:29

Publisher DOI:

10.1016/j.jacc.2011.05.050

PubMed ID:

21958884

Web of Science ID:

000295868000005

URI:

https://boris.unibe.ch/id/eprint/7212 (FactScience: 212398)

Actions (login required)

Edit item Edit item
Provide Feedback